Advertisement

BMC Psychiatry

, 20:19 | Cite as

Mortality and risk assessment for anorexia nervosa in acute-care hospitals: a nationwide administrative database analysis

  • Shunsuke Edakubo
  • Kiyohide FushimiEmail author
Open Access
Research article
Part of the following topical collections:
  1. Eating disorders

Abstract

Background

Anorexia nervosa (AN) is a common eating disorder with the highest mortality rate of all psychiatric diseases. However, few studies have examined inpatient characteristics and treatment for AN. This study aimed to characterise the association between mortality and risk factors in patients with AN in acute-care hospitals.

Methods

We conducted a nationwide, retrospective analysis of the Japanese Diagnosis and Procedure Combination inpatient database. Data extraction occurred from April 2010 to March 2016. We estimated in–hospital mortality and identified independent risk factors, using multivariate logistic regression analysis to examine patient characteristics and physical and psychological comorbidities.

Results

We identified 6937 patients with AN aged ≥12 years in 885 acute-care hospitals. Of these, 361 (5.2%) were male. Male and female participants’ median ages at first admission were 34 (17–65) and 28 (17–41) years, respectively. In total, 195 in-hospital patient deaths, including 22 (6.1%) men and 173 (2.6%) women, it was observed that the unadjusted odds ratio of mortality for male patients was more than twice that for female patients (OR: 2.40, 95% CI: 1.45–3.81). Multivariate logistic regression analysis demonstrated an adjusted odds ratio of 2.19 (95% CI: 1.29–3.73). Age at first hospital admission, percentage of ideal body weight, comorbidities, and hypotension were significantly associated with increased mortality risk, but the frequency of hospitalization, bradycardia, and other psychiatric disorders were not. Treatment in a university hospital was associated with lower mortality risk (odds ratio: 0.45, 95% CI: 0.30–0.67).

Conclusion

The results highlighted sex differences in mortality rates. Potential risk factors could contribute to improved treatment and outcomes. These retrospective findings indicate a need for further longitudinal examination of these patients.

Keywords

Anorexia nervosa Mortality Risk factor Sex difference 

Abbreviations

AN

Anorexia nervosa

BMI

Body mass index

CI

Confidence interval

DPC

Diagnosis and procedure combination

ICD-10

International classification of diseases, 10th revision (ICD-10)

IQR

Interquartile range

OR

Odds ratio

SD

Standard deviation

Background

Anorexia nervosa (AN) is a common eating disorder. It is observed mainly in women aged 10–20 years and is associated with high levels of psychological stress or anxiety related to the pursuit of thinness or fear of fatness [1]. These stress are anxiety are specific to this age group. It is mainly present in socio–economically developed countries and in these countries, the prevalence of AN has increased significantly because of socio-cultural traditions involving the admiration of fashion models and thinner women [2].

In Japan, initial outpatient treatment of stable AN often involves primary care physicians or psychiatrists, and includes interventions such as monitoring weight, nutritional rehabilitation, education for patients and family, or cognitive behavioural therapy. Once patients fail to respond to these initial interventions and demonstrate physical or psychiatric instability, hospitalisation is recommended. When their physical conditions are severe, initial treatment is often provided by internal medicine or critical care physicians who are accustomed to using hemodynamic agents.

AN exhibits various physical and psychiatric complications, depending on severity, including medical problems such as hypotension, bradycardia, and arrythmia due to electrolyte abnormality and infection due to low white blood cell count [3]. A common clinical choice in nutritional rehabilitation could be enteral nutrition with a feeding tube; however, patients may experience various symptoms ranging from abdominal pain or discomfort to refeeding syndrome [3, 4]. Therefore, these complexities of nutritional management result in time and cost consumption in the remission of AN patients’ weight [5, 6].

The complexities of management of issues other than nutrition also worsen the prognoses of AN patients. Of all psychiatric disorders, it is observed that AN is associated with the highest mortality rate, which is five times that observed in the general population according to age and sex [7, 8].

The recovery rates ranged from 0 to 92% in a previous review [9]. One of the reasons for this wide discrepancy could be the variety of definitions of recovery, and another could be the power of the evidence in the guidelines for AN [10, 11, 12, 13, 14], which were established based on a limited number of patients because of the accumulation of rare diseases. Consequently, a limited number of epidemiological studies have been conducted; in particular, no studies have examined risk according to patients’ background characteristics such as sex, age, and expressions of clinical symptoms.

The purpose of this study was to explore patients’ demographic characteristics and examine what characteristics were risks for AN mortality, using a large Japanese administrative database.

Methods

Study design

We conducted a nationwide, retrospective cohort study using a Japanese administrative inpatient database known as the Diagnosis Procedure Combination (DPC) database, which includes claims and discharge data from more than 1000 participating hospitals and holds information from more than 90% of all tertiary-care emergency hospitals in Japan. The database includes the following patient information: age; sex; primary diagnosis; comorbidities at admission; complications after admission classified according to International Classification of Diseases, 10th revision (ICD-10) codes; medical procedures coded with original Japanese codes; daily records of drug administration and devices used; duration of stay; and discharge status. Dates of hospital admission, surgical and nonsurgical procedures, drugs administered, and discharge are recorded using a uniform data submission format.

Although the DPC database lacks information regarding physiological and laboratory measures (e.g. blood pressure and the results of blood tests), it has been validated for many other outcomes, types of exposure, and comorbidities.

Patient selection

Data from April 2010 to March 2016 were used for this study. To identify patients with AN, we extracted patient data from the database according to the following procedure. We extracted data for patients diagnosed with an eating disorder (ICD-10 codes: F500, F501, F502, F503, F504, and F505) as the main disease, the reason for admission, or a comorbid disorder. We then selected patients whose body weight during hospitalization was below 75% of their ideal weight. As some patients’ weight was more than 75% of their ideal weight because of binge eating, we included patients who had been hospitalised with weight of less than 75% of their ideal weight at least once. We excluded patients who: 1) were younger than 11 years of age; 2) were discharged or died within 2 days of admission, to avoid immortal time bias [15]; 3) were below 1 m in height, which is less than − 3 standard deviations (SDs) of the mean height for 11-year-old children [16]; 4) had missing data for weight; or 5) had been diagnosed with digestive carcinoma as they could not, rather than would not, eat.

Study variables and outcomes

Variables included age, sex, thinness index (defined as the ratio of actual weight to their ideal weight. We calculated ideal weight according to Kato et al.’s methods [16] if they were younger than 18 years or body mass index (BMI) of 22 if they were 18 years or older. As part of school health, body height and weight of the students are recorded officially [17]. According to these data, ideal adolescent weight by age and gender were different from adults: BMI 22 is not an ideal indicator especially for the younger generation in Japan), updated Charlson Comorbidity Index calculated via Quan et al.’s algorithms [18]: predicts 10-year survival in patients with multiple comorbidities, hospital type (i.e. university or non-university), frequency of hospitalisation, use of catecholamine within the first 48 h of admission, commonly prescribed for hypotension, use of atropine within the first 48 h of admission, commonly prescribed for bradycardia, other psychological disorders, and binge eating and purging. The main outcome of the study was all-cause in-hospital mortality.

Statistical analysis

Descriptive statistics are presented as means and SDs or medians with interquartile ranges (IQRs) for continuous variables and frequencies with percentages for categorical variables. Comparisons of continuous variables were performed using the Wilcoxon rank sum test, because the distribution of the continuous variables was far from the normal distribution. The chi-square test was used to compare categorical variables. We calculated the all-cause in-hospital mortality rate with an exact 95% CI. Multivariate logistic regression models were created to identify potential risk factors for in-hospital mortality.

Subgroup analysis

Two subgroup analyses were performed. The first subgroup analysis was restricted to patients below 60 years to make the diagnosis credible, as a previous study [19]. The second subgroup analysis was conducted on patients who survived. As a cycle of remission and exacerbation is common in eating disorders, prognoses are likely to worsen. Therefore, some patients are admitted to hospital repeatedly. However, the effects of baseline characteristics and treatment on repeated admissions remain unclear. Consequently, in the second subgroup analysis, we investigated the factors that influenced readmission.

The factors examined included patient characteristics, hospital type, and treatment. We selected treatment factors according to the following variables: major surgery such as craniotomy, open heart surgery, thoracotomy, laparotomy, general anaesthesia, blood transfusions, administration of anti–arrhythmia agents, intravenous hyperalimentation, and psychotherapy. These factors were also analysed via a multivariate logistic regression model.

Sensitivity analysis

To ensure the robustness of the analysis, we conducted sensitivity analysis including the treatment effects used in the subgroup and original analyses.

All analyses were performed using R software version 3.4.3 (R Foundation for Statistical Computing, Vienna, Austria). The analyses were two-tailed, and p values of <.05 were considered statistically significant.

Results

Over seven years, 6937 patients from 885 hospitals met the inclusion criteria. They represented 11066 hospitalisation occurrences; 9165 (82.8%) occurrences were for psychiatric reasons and 1901 (17.2%) were for medical/surgical reasons. Of these patients, 361 (5.2%) were men and represented 465 (4.2%) hospitalization occurrences, and 6576 (94.8%) were women and represented 10601 (95.8%) hospitalization occurrences. Patient characteristics are shown in Table 1.
Table 1

Patient characteristics and in-hospital deaths

 

n (%)

Deaths (%)

p value

Total

6937

195 (2.8)

 

Sex

 

<.001

 Male

361 (5.2)

22 (6.1)

 

 Female

6576 (94.8)

173 (2.6)

 

Age at first hospitalization

 

0.009

 12–15

1373 (19.8)

2 (0.0)

 

 16–19

942 (13.6)

7 (0.1)

 

 20–29

1262 (18.2)

18 (0.3)

 

 30–39

1305 (18.8)

41 (0.6)

 

 40–49

1060 (15.3)

41 (0.6)

 

 50–59

485 (7.0)

27 (0.4)

 

 60–69

196 (2.8)

17 (0.2)

 

 70–79

148 (2.1)

15 (0.2)

 

  ≥ 80

166 (2.4)

27 (0.4)

 

Proportion of actual weight to ideal weight (SD)

 

<.001

 

61.5 (9.1)

55.0 (9.4)

 

Charlson Comorbidity Index

 

<.001

 0

5913 (85.2)

127 (1.8)

 

 1

189 (2.7)

13 (0.2)

 

 2

724 (10.4)

38 (0.5)

 

  ≥ 3

111 (1.6)

17 (0.2)

 

Hospital Type

 

<.001

 University

3047 (43.9)

163 (2.3)

 

 Non-university

3890 (56.1)

32 (0.5)

 

Frequency of hospitalization

 

0.128

 1

4940 (71.2)

154 (2.2)

 

 2

1141 (16.4)

23 (0.3)

 

 3

401 (5.8)

10 (0.1)

 

 4

210 (3.0)

2 (0.0)

 

 5

70 (1.0)

3 (0.0)

 

  ≥ 6

166 (2.4)

3 (0.0)

 

 Maximum

30

8

 

Physical status at admission

  

 Bradycardia

43 (0.6)

1 (0.0)

0.999

 Hypotension

146 (2.1)

34 (0.5)

<.001

Other psychological disorder

  

 Anxiety disorder

678 (9.8)

7 (0.1)

0.002

 Mood disorder

898 (12.9)

20 (0.3)

0.329

 Schizophrenia

533 (7.7)

12 (0.2)

0.496

 Binge eating and purging

745 (10.7)

10 (0.1)

0.009

Participants’ median ages at first hospitalization were 34 (IQR: 17–65) for male patients and 28 (IQR: 17–41) for female patients (p < .001). The results showed that there were 195 in-hospital deaths (2.8%; 95% CI: 2.4–4.3%), which included 22 men (6.5%; 95% CI: 3.9–9.1%) and 173 women (2.6%; 95% CI: 2.2–3.0%). It was observed that the unadjusted odds ratio of mortality for male patients was more than twice that for female patients (OR: 2.40, 95% CI: 1.45–3.81, p < .001).

The percentages of ideal weight were relatively low for deceased patients (61.7% for alive patients, 55.0% for deceased patients).

Table 1 also shows the physical and psychological complications for all patients and cases involving death. For approximately 90% of patients, Charlson Comorbidity Index values were < 2. This indicated that the majority of eligible patients were basically healthy. Hemodynamic instability was rare, and the complication rate for psychological disorders was approximately 10%.

The results of the multivariate logistic regression model are shown in Table 2. The model showed good discrimination (c statistic = 0.935; 95% CI: 0.918–0.952). After adjustment for multiple potential risk factors, male sex showed an OR of 2.19 (95% CI: 1.29–3.73, p = .004) for risk of mortality. Among the potential risk factors, age, thinness index, comorbidities, hospital type, and use of catecholamines were significantly associated with mortality; however, frequency of hospitalization, use of atropine, other mental disorders, and binge eating and purging were not. Treatment in a university hospital was associated with a lower OR, relative to those observed for other risk factors, for in-hospital mortality.
Table 2

Risk factors for in-hospital deaths: multivariate logistic regression

 

OR

95% CI

p-value

Sex (ref. female)

 Male

2.19

1.29–3.73

.004

Age at first admission

1.05

1.04–1.06

<.001

Ratio of actual weight to ideal body weight (thinness index)

0.92

0.90–0.94

<.001

Charlson Comorbidity Index

1.27

1.14–1.42

<.001

Hospital type (ref. non-university)

 University

0.45

0.30–0.67

<.001

Frequency of hospitalization

0.92

0.79–1.08

.322

Use of catecholamine

8.65

5.45–13.7

<.001

Use of atropine

0.27

0.03–2.12

.213

Other psychological disorders

 

 Anxiety disorder

0.47

0.22–1.04

.063

 Mood disorder

0.80

0.49–1.31

.376

 Schizophrenia

0.99

0.53–1.86

.976

 Binge eating and purging

1.47

0.71–3.02

.296

Table 3 shows the results of a subgroup analysis using age-restricted patients. The results of the age-restricted analysis were similar to those observed in the main analysis (OR: 2.40, 95% CI: 1.00–5.73 for males compared to females).
Table 3

Risk factors for patients aged under 60 years in 6454 patients: multivariate logistic regression

 

OR

95% CI

p-value

Sex (ref. female)

 Male

2.40

1.00–5.73

.049

Age at first admission

1.04

1.03–1.06

<.001

Ratio of actual weight to ideal body weight (thinness index)

0.91

0.89–0.93

<.001

Charlson Comorbidity Index

1.28

1.11–1.49

<.001

Hospital type (ref. non-university)

 University

0.45

0.30–0.69

<.001

Frequency of hospitalization

0.93

0.79–1.10

.399

Use of catecholamine

9.82

6.00–16.10

<.001

Use of atropine

0.27

0.03–2.19

.221

Other psychological disorders

 

 Anxiety disorder

0.54

0.23–1.27

.157

 Mood disorder

0.83

0.45–1.52

.550

 Schizophrenia

0.72

0.34–1.54

.397

 Binge eating and purging

1.69

0.78–3.65

.180

The results of the subgroup analysis on the risk for re-admission is shown in Table 4. In contrast to the main analysis, the OR for men was small relative to that observed for women (OR: 0.60, 95% CI: 0.43–0.84). Most factors were related to the risk of re–admission.
Table 4

Risk factors related to re-admission: multivariate logistic regression

 

OR

95% CI

p-value

Sex (ref. female)

 Male

0.60

0.43–0.84

.003

Age at first admission

0.99

0.99–0.99

.008

Ratio of actual weight to ideal body weight (thinness index)

0.99

0.98–0.99

<.001

Charlson Comorbidity Index

1.28

1.12–1.38

<.001

Hospital type (ref. non-university)

 University

1.47

1.30–1.67

<.001

Use of catecholamine

1.90

1.19–3.03

.007

Use of atropine

0.67

0.29–1.54

.341

Other psychological disorders

 Anxiety disorder

1.94

1.60–2.36

<.001

 Mood disorder

1.76

1.47–2.09

<.001

 Schizophrenia

2.58

2.09–3.19

<.001

 Binge eating and purging

32.60

19.7–54.10

<.001

Psychotherapy

2.56

2.01–3.26

<.001

Intravenous hyperalimentation

1.99

1.75–2.26

<.001

Major surgery

1.87

0.85–4.15

.123

General anaesthesia

2.12

1.28–3.52

.004

Blood transfusion

0.70

0.45–1.10

.122

Use of anti-arrhythmia agents

1.98

0.94–4.17

.072

The results of the sensitivity analysis, including treatment effects, are shown in Table 5. Of the treatment factors, major surgery was not associated with higher OR (OR: 0.98, 95%CI: 0.13–7.52). After adjustment for treatment effects, mortality for men remained approximately twice that observed for women (OR: 1.94, 95% CI: 1.12–3.38).
Table 5

Risk factors for in-hospital deaths: multivariate logistic regression

 

OR

95% CI

p-value

Sex (ref. female)

 Male

1.94

1.12–3.38

.019

Age at first admission

1.04

1.03–1.05

<.001

Proportion of actual weight to ideal body weight (thinness index)

0.93

0.91–0.95

<.001

Charlson Comorbidity Index

1.22

1.09–1.37

<.001

Hospital type (ref. non-university)

 Academic

0.48

0.31–0.75

.001

Frequency of hospitalization

0.93

0.79–1.09

.373

Use of catecholamine

3.76

2.21–6.39

<.001

Use of atropine

0.07

0.06–0.91

.042

Other psychological disorders

 Anxiety disorder

0.59

0.26–1.33

.203

 Mood disorder

0.80

0.48–1.35

.406

 Schizophrenia

1.03

0.52–2.03

.938

 Binge eating and purging

0.20

0.09–0.45

<.001

Psychotherapy

0.38

0.27–0.53

<.001

Intravenous hyperalimentation

2.25

1.54–3.28

<.001

Major surgery

0.98

0.13–7.52

.985

General anaesthesia

0.11

0.002–0.46

.003

Blood transfusion

9.81

6.13–15.7

<.001

Use of anti-arrhythmia agents

5.23

2.25–12.2

<.001

Discussion

To our knowledge, this was the first study conducted using a large-scale database to demonstrate sex differences in risk factors in patients with AN. These data showed that the in-hospital mortality rate for this patient group was approximately 3%, and the mortality rate for male patients was more than twice that for female patients. This increase was not explained by differences in patients’ baseline characteristics, clinical expression, or other mental disorders.

Only one previous study conducted in a single centre showed that the 3-year mortality rate for male AN patients was higher than for female patients [20]. The authors hypothesised that men received less social support after discharge than women. The current study showed that men’s age at first hospitalization was higher relative to that of women. One possible explanation for this finding could be that delayed intervention or insufficient recognition of the severity by both patients and medical staff contributed to the worsening of outcomes.

In the subgroup analysis, we demonstrated that men were less likely to be re-admitted relative to women. This result could be explained by sex differences. Male patients could have received inadequate interventions and been hospitalised only when they were in a more fragile state, relative to female patients, for various reasons. The lack of an association between the frequency of hospitalization and higher mortality rates in the main analysis could also explain this. These findings suggest that early and multiple advanced medical interventions could be favourable. AN is relatively rare and clinically atypical in male patients; therefore, it requires careful treatment.

We also demonstrated for the first time that treatment at a university hospital exerted a favourable effect on mortality. The management of AN patients is complicated by not only psychotherapy but also supportive care. For example, titration of drug administration is important, as abnormal distribution volumes could cause pharmacodynamics to differ from those observed in healthy individuals, and refeeding syndrome during enteral nutrition could also be a critical problem [21, 22, 23]. The newest ESPEN guidelines support multimodal nutrition for patients at high risk of preoperative conditioning [24]. From these perspectives, involving several experts in treatment is reasonable, and the lower OR observed for university hospitals, relative to those observed for other hospitals, could have resulted from the involvement of many experts and departments in patient care, which is emphasised by several guidelines and reports [10, 11, 12, 13, 14, 25]. The findings of the current study support the notion that multi-professional interventions contribute to better outcomes.

The sensitivity analysis showed several treatment risks. For example, critical hypotension, arrhythmia, and blood transfusions were associated with higher mortality, but major operations and general anaesthesia were not. According to the “obesity paradox,” underweight patients are at increased risk of mortality in general surgical procedures relative to patients of a healthy weight [26, 27]. Improvement of the management of these conditions via short-acting drugs or advanced monitoring devices could contribute to better outcomes. The results indicated that when patients require surgical intervention, practitioners should not hesitate to provide this, as there might not be time to hesitate.

The study was subject to several limitations. For example, as the DPC database is based on diagnoses recorded by attending physicians, these diagnoses could have been less valid relative to those in prospective studies. Due to the limitation in that we could not access behavioural criteria (i.e. pursuit of thinness or fear of fat) or associated symptoms, our samples might include individuals with avoidant-restrictive food intake disorder as classified in DSM-V or other low weight conditions.

In addition, the DPC database does not include clinical or physiological information such as that regarding hypotension or arrhythmia. Although we substituted the use of medications for this information, we could not adjust for these factors using actual blood pressure values or types of arrhythmia.

Moreover, we could not identify the history or duration of AN or the time of onset. Therefore, we could not identify medical or psychiatric treatment before hospitalization. We examined the data for a long period (7 years); however, because AN is a disease that is sometimes treated over the life span [28], this could have been insufficient.

Further, because of the database design, our assessment of hospital readmission was limited to individuals admitted to the same hospital. Therefore, we could identify only individuals using the same index if they had been readmitted to the same hospital. If patients were admitted to different hospitals, they were regarded as different patients with different index values. Therefore, we could have duplicated data for some patients, and the actual number of patients could have been lower.

The database design was also a study limitation, as when patients received home–based care or were admitted to psychiatric hospitals, their data were not included in the DPC database, and their mortality rate was unknown. As psychiatric hospitals are relatively scarce (approximately one-seventh of traditional hospitals in Japan [29], this factor could have exerted a weak impact on overall mortality.

Conclusion

This study showed that the risk of mortality in male AN patients was more than twice that of female AN patients. Age at first admission, the proportion of actual weight to ideal body weight, comorbidities, and hypotension were potential risk factors for mortality. However, the receipt of treatment at university hospitals exerted a favourable effect. Major surgery and general anaesthesia may not worsen the outcomes. Recognition of and preparation for the risk factors identified in this study could contribute to improved outcomes. Further longitudinal examination of AN patients is required.

Notes

Acknowledgements

We would like to thank Editage (www.editage.jp) for English-language editing.

Authors’ contributions

All authors contributed to the study concept and design and the acquisition of data. SE performed the statistical analysis, SE drafted the manuscript, and KF contributed to data interpretation and manuscript revision. All authors approved the manuscript. SE is the guarantor. The corresponding author attests that all listed authors meet the authorship criteria, and no other individuals meeting the criteria have been omitted.

Funding

The study was supported by a Grant-in-Aid for Research on Policy Planning and Evaluation from the Ministry of Health, Labour and Welfare, Japan (H28-Seisaku-Shitei-009) and a Grant-in Aid for Scientific Research C (No. 15 K00838) from the Ministry of Evaluation, Culture, Sports, Science and Technology, Japan.

The funding body had no role in study design, data collection, analysis, interpretation, or writing of the report.

Ethics approval and consent to participate

The study was approved by the institutional review board at Tokyo Medical and Dental University. Because of the anonymous nature of the data, the board waived the requirement for informed patient consent.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

References

  1. 1.
    Bulik CM, Sullivan PF, Tozzi F, Furberg H, Lichtenstein P, Pedersen NL. Prevalence, heritability, and prospective risk factors for anorexia nervosa. Arch Gen Psychiatry. 2006;63:305–12.  https://doi.org/10.1001/archpsyc.63.3.305.CrossRefPubMedGoogle Scholar
  2. 2.
    Pavlova B, Uher R, Dragomirecka E, Papezova H. Trends in hospital admissions for eating disorders in a country undergoing a socio-cultural transition, the Czech Republic 1981–2005. Soc Psychiatry Psychiatr Epidemiol. 2010;45:541–50.  https://doi.org/10.1007/s00127-009-0092-7.CrossRefPubMedGoogle Scholar
  3. 3.
    Yager J, Andersen AE. Clinical practice Anorexia Nervosa. N Engl J Med. 2005;353:1481–8.  https://doi.org/10.1056/NEJMcp050187.CrossRefPubMedGoogle Scholar
  4. 4.
    Seller CA, Ravalia A. Anaesthetic implications of anorexia nervosa. Anaesthesia. 2003;58:437–43.  https://doi.org/10.1046/j.1365-2044.2003.03130.x.CrossRefPubMedGoogle Scholar
  5. 5.
    Couturier J, Lock J. What is recovery in adolescent anorexia nervosa? Int J Eat Disord. 2006;39:550–5.  https://doi.org/10.1002/eat.20309.CrossRefPubMedGoogle Scholar
  6. 6.
    Morris J, Simpson AV, Voy SJ. Length of stay of inpatients with eating disorders. Clin Psychol Psychother. 2015;22:45–53.  https://doi.org/10.1002/cpp.1865.CrossRefPubMedGoogle Scholar
  7. 7.
    Morris J, Twaddle S. Anorexia nervosa. BMJ. 2007;334:894–8.  https://doi.org/10.1136/bmj.39171.616840.BE.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Jassogne C, Zdanowicz N. Management of adult patients with anorexia nervosa: a literature review. Psychiatria Danub. 2018;30(Suppl. 7):533–6.Google Scholar
  9. 9.
    Steinhausen HC. The outcome of anorexia nervosa in the 20th century. Am J Psychiatry. 2002;159:1284–93.  https://doi.org/10.1176/appi.ajp.159.8.1284.CrossRefPubMedGoogle Scholar
  10. 10.
    Yager J, Devlin MJ, Halmi KA, et al. Guideline watch (August 2012): practice guideline for the treatment of patients with eating disorders. 3rd ed. Washington, DC: APA; 2012. Available at: https://psychiatryonline.org/pb/assets/raw/sitewide/practice_guidelines/guidelines/eatingdisorders-watch.pdf Accessed 25 Mar 2019Google Scholar
  11. 11.
    Hay P, Chinn D, Forbes D, et al. Royal Australian and new Zealand College of Psychiatrists clinical practice guidelines for the treatment of eating disorders. Aust N Z J Psychiatry. 2014;48:977–1008.  https://doi.org/10.1177/0004867414555814.CrossRefPubMedGoogle Scholar
  12. 12.
    National Institute for Health and Care Excellence (NICE). Eating disorders: recognition and treatment, full guideline. 2017; Available at: https://www.nice.org.uk/guidance/ng69 Accessed 25 Mar 2019.Google Scholar
  13. 13.
    Ebeling H, Tapanainen P, Joutsenoja A, et al. A practice guideline for treatment of eating disorders in children and adolescents. Ann Med. 2003;35:488–501.  https://doi.org/10.1080/07853890310000727.CrossRefPubMedGoogle Scholar
  14. 14.
    American Academy of Pediatrics. Committee on Adolescence. Identifying and treating eating disorders. Pediatrics. 2003;111:204–11.  https://doi.org/10.1542/peds.111.1.204.CrossRefGoogle Scholar
  15. 15.
    Suissa S. Immortal time bias in pharmacoepidemiology. Am J Epidemiol. 2008;167:492–9.  https://doi.org/10.1093/aje/kwm324.CrossRefPubMedGoogle Scholar
  16. 16.
    Kato N, Takimoto H, Sudo N. The cubic functions for spline smoothed L, S and M values for BMI reference data of Japanese children. Clin Pediatr Endocrinol. 2011;20:47–9.  https://doi.org/10.1297/cpe.20.47.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Annual Report of School Health Statistics Research in Japan. https://www.e-stat.go.jp/stat-search/files?page=1&toukei=00400002&tstat=000001011648&cycle=0&second2=1 (in Japanese) Accessed 25 Mar 2019.
  18. 18.
    Quan H, Li B, Couris CM, et al. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol. 2011;173:676–82.  https://doi.org/10.1093/aje/kwq433.CrossRefPubMedGoogle Scholar
  19. 19.
    Michihata N, Matsui H, Fushimi K, Yasunaga H. Comparision between enteral nutrition and intravenous hyperalimentation in patients with eating disorders: results from the Japanese diagnosis procedure combination database. Eat Weight Disord. 2014;19:473–8.  https://doi.org/10.1007/s40519-014-0147-y.CrossRefPubMedGoogle Scholar
  20. 20.
    Gueguen J, Godart N, Chambry J, et al. Severe anorexia nervosa in men: comparison with severe AN in women and analysis of mortality. Int J Eat Disord. 2012;45:537–45.  https://doi.org/10.1002/eat.20987.CrossRefPubMedGoogle Scholar
  21. 21.
    Bally MR, Blaser Yildirim PZ, Bounoure L, et al. Nutritional support and outcomes in malnourished medical inpatients: a systematic review and meta-analysis. JAMA Intern Med. 2016;176:43–53.  https://doi.org/10.1001/jamainternmed.2015.6587.CrossRefPubMedGoogle Scholar
  22. 22.
    Friedli N, Stanga Z, Sobotka L, et al. Revisiting the refeeding syndrome: results of a systematic review. Nutrition. 2017;35:151–60.  https://doi.org/10.1016/j.nut.2016.05.016.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Mehanna HM, Moledina J, Travis J. Refeeding syndrome: what it is, and how to prevent and treat it. BMJ. 2008;336:1495–8.  https://doi.org/10.1136/bmj.a301.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Weimann A, Braga M, Carli F, et al. ESPEN guideline: clinical nutrition in surgery. Clin Nutr. 2017;36:623–50.  https://doi.org/10.1016/j.clnu.2017.02.013.CrossRefPubMedGoogle Scholar
  25. 25.
    McIntosh VVW, Jordan J, Luty SE, et al. Specialist supportive clinical management for anorexia nervosa. Int J Eat Disord. 2006;39:625–32.  https://doi.org/10.1002/eat.20297.CrossRefPubMedGoogle Scholar
  26. 26.
    Mullen JT, Moorman DW, Davenport DL. The obesity paradox: body mass index and outcomes in patients undergoing nonbariatric general surgery. Ann Surg. 2009;250:166–72.  https://doi.org/10.1097/SLA.0b013e3181ad8935.CrossRefPubMedGoogle Scholar
  27. 27.
    Yasunaga H, Horiguchi H, Matsuda S, Fushimi K, Hashimoto H, Ayanian JZ. Body mass index and outcomes following gastrointestinal cancer surgery in Japan. Br J Surg. 2013;100:1335–43.  https://doi.org/10.1002/bjs.9221.CrossRefPubMedGoogle Scholar
  28. 28.
    Ficher MM, Quadfleig N, Crosby RD, Koch S. Long-term outcome of anorexia nervosa: results from a large clinical longitudinal study. Int J Eat Disord. 2017;50:1018–30.  https://doi.org/10.1002/eat.22736.CrossRefGoogle Scholar
  29. 29.
    Summary of Static/Dynamic Survey of Medical Institutions and Hospital Report 2017. https://www.mhlw.go.jp/toukei/saikin/hw/iryosd/17/dl/09gaikyo29.pdf (in Japanese) Accessed 16 June 2019.

Copyright information

© The Author(s). 2020

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors and Affiliations

  1. 1.Department of Health Policy and InformaticsTokyo Medical and Dental University Graduate SchoolTokyoJapan

Personalised recommendations